AviadoBio

Developer of transformative gene therapies designed to transform people living with devastating neurodegenerative diseases. The company's platform combines diseases such as frontotemporal dementia and amyotrophic lateral sclerosis with a deep understanding of the brain and a suite of proprietary gene therapies to overcome the challenges of delivering the right drug to the right place, enabling patients to maximize the therapeutic potential of gene therapy to halt or potentially reverse neurodegenerative diseases.

New Enterprise Associates

🏥 Healthcare